1.65
price up icon13.01%   0.19
after-market Dopo l'orario di chiusura: 1.65
loading
Precedente Chiudi:
$1.46
Aprire:
$1.61
Volume 24 ore:
121.98K
Relative Volume:
0.05
Capitalizzazione di mercato:
$17.55M
Reddito:
-
Utile/perdita netta:
$-39.14M
Rapporto P/E:
-0.2764
EPS:
-5.97
Flusso di cassa netto:
$-28.20M
1 W Prestazione:
+10.74%
1M Prestazione:
+60.19%
6M Prestazione:
-47.62%
1 anno Prestazione:
-92.90%
Intervallo 1D:
Value
$1.61
$1.67
Intervallo di 1 settimana:
Value
$1.4009
$1.67
Portata 52W:
Value
$0.65
$26.25

Citius Pharmaceuticals Inc Stock (CTXR) Company Profile

Name
Nome
Citius Pharmaceuticals Inc
Name
Telefono
(908) 967-6676
Name
Indirizzo
11 COMMERCE DRIVE, CRANFORD, NJ
Name
Dipendente
23
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-07
Name
Ultimi documenti SEC
Name
CTXR's Discussions on Twitter

Confronta CTXR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CTXR
Citius Pharmaceuticals Inc
1.65 16.31M 0 -39.14M -28.20M -5.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-30 Aggiornamento D. Boral Capital Hold → Buy
2021-11-30 Iniziato Maxim Group Buy

Citius Pharmaceuticals Inc Borsa (CTXR) Ultime notizie

pulisher
Jul 23, 2025

What drives Citius Pharmaceuticals Inc. stock priceHigh-yield portfolio picks - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Citius Pharmaceuticals Inc. a good long term investmentFree Stock Market Knowledge Sharing - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Citius Pharmaceuticals Inc. stockRecord-setting profit potential - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Citius Pharmaceuticals Inc. Stock Analysis and ForecastHigh-profit stock alerts - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Citius Oncology Announces Closing of $9.0 Million Public Offering - Eastern Progress

Jul 19, 2025
pulisher
Jul 17, 2025

Citius Oncology closes $9 million public offering to support LYMPHIR - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology closes $9 million public offering to support LYMPHIR By Investing.com - Investing.com Nigeria

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology Raises $9M in Public Offering for LYMPHIR Commercialization - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology Announces Pricing Of $9M "Reasonable Best-Efforts" Public Offering Of 6,818,182 Shares Of Common Stock And Warrants To Purchase Shares Of Common Stock At A Public Offering Price Of $1.32 Per Share - 富途牛牛

Jul 17, 2025
pulisher
Jul 17, 2025

Cencora distribution deal boosts Citius shares - MSN

Jul 17, 2025
pulisher
Jul 16, 2025

Citius Pharmaceuticals shares fall 1.34% after-hours following Citius Oncology's public offering. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology Announces Pricing of $9.0 Million Public Offering - Finansavisen

Jul 16, 2025
pulisher
Jul 15, 2025

Citius Oncology (CTOR): Is LYMPHIR's Launch Priced for Success? - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology: Is A Lymphir Launch Coming Too Late? - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Pharmaceuticals (CTXR) Surges on New Distribution Deal - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology stock rises after expanding LYMPHIR distribution network By Investing.com - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology stock rises after expanding LYMPHIR distribution network - Investing.com Australia

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology Expands Lymphir Distribution With Cencora - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology expands distribution network for LYMPHIR with Cencora - Investing.com Australia

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology expands distribution network for LYMPHIR with Cencora By Investing.com - Investing.com Canada

Jul 15, 2025
pulisher
Jul 15, 2025

Citius stock gains on Cencora distribution deal (CTXR:NASDAQ) - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Pre-market Movers: KAPA, CYCC, SONN, RANI... - RTTNews

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora - WV News

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Pharmaceuticals Soars 10.18% on Nasdaq Compliance - AInvest

Jul 15, 2025
pulisher
Jul 14, 2025

Citius Pharmaceuticals' Strategic Financing: Balancing Dilution Risks with LYMPHIR's Commercial Potential - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

Citius Oncology Plans Stock Offering; Shares Down - MarketScreener

Jul 14, 2025
pulisher
Jul 11, 2025

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) On The Verge Of Breaking Even - simplywall.st

Jul 11, 2025
pulisher
Jul 10, 2025

Citius Pharmaceuticals regains Nasdaq compliance - MSN

Jul 10, 2025
pulisher
Jul 09, 2025

Citius Pharmaceuticals Regains Nasdaq Compliance - The Globe and Mail

Jul 09, 2025
pulisher
Jul 08, 2025

CTXR SEC FilingsCitius Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 08, 2025
pulisher
Jul 08, 2025

Citius Pharmaceuticals regains Nasdaq compliance after 10-day streak - Investing.com

Jul 08, 2025
pulisher
Jul 08, 2025

Citius Pharmaceuticals regains Nasdaq compliance after 10-day streak By Investing.com - Investing.com UK

Jul 08, 2025
pulisher
Jul 08, 2025

Citius Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement - 富途牛牛

Jul 08, 2025
pulisher
Jul 08, 2025

Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - Finansavisen

Jul 08, 2025
pulisher
Jul 06, 2025

Citius Pharmaceuticals: LYMPHIR Launch Ignites High-Growth Potential in CTCL Market - AInvest

Jul 06, 2025
pulisher
Jul 06, 2025

Citius Pharmaceuticals Prepares for Q2 2025 Commercial Launch of FDA-Approved Cancer Drug LYMPHIR - Insider Monkey

Jul 06, 2025

Citius Pharmaceuticals Inc Azioni (CTXR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):